OptimizeRx Corporation

Equities

OPRX

US68401U2042

Internet Services

Real-time Estimate Cboe BZX 09:42:29 2024-04-16 am EDT 5-day change 1st Jan Change
10.32 USD +0.05% Intraday chart for OptimizeRx Corporation -7.19% -27.88%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M MT
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26 MT
OptimizeRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
JMP Securities Initiates Coverage on OptimizeRx With Market Perform Rating, $15 Price Target MT
OptimizeRx Expected to Meet 2024 Guidance, RBC Says; Shares Drop MT
Transcript : OptimizeRx Corporation, Q4 2023 Earnings Call, Mar 28, 2024
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023. CI
OptimizeRx Corp. Powers Walmart's ?Specialty Pharmacies of the Community? Outreach Effort CI
OptimizeRx Corporation Announces Changes to its Board CI
RBC Adjusts OptimizeRx's Price Target to $17 From $14, Keeps Outperform Rating MT
OptimizeRx Shares Jump as Preliminary 2023 Revenue Tops Guidance MT
OptimizeRx Corporation Revises Earnings Guidance for the Year 2023 CI
Barclays Starts OptimizeRx With Equalweight Rating, $15 Price Target MT
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023. CI
Transcript : OptimizeRx Corporation, Q3 2023 Earnings Call, Nov 06, 2023
OptimizeRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q3 Revenue $16.3M, vs. Street Est of $15.1M MT
OptimizeRx Corporation Provides Earnings Guidance for the Year 2024 CI
OptimizeRx Corporation Increases Earnings Guidance for the Year 2023 CI
North American Morning Briefing : Stocks Look to -2- DJ
OptimizeRx Corporation completed the acquisition of Healthy Offers, Inc. from a group of shareholders. CI
Optimizerx Corporation to Change the Designation of Stephen L. Silvestro from Chief Commercial Officer to President CI
Transcript : Healthy Offers, Inc., OptimizeRx Corporation - M&A Call
OptimizeRx Agrees to Acquire Medicx Health for $95 Million; Issues Q3 Non-GAAP Net Income, Revenue Expectations MT
OptimizeRx Corporation Provides Preliminary Financial Guidance for the Third Quarter Ended September 30, 2023 CI
Chart OptimizeRx Corporation
More charts
OptimizeRx Corporation is a digital health technology company, which enables engagement between life sciences organizations, healthcare providers and patients. The Company's principal solutions include evidence-based physician engagement, point of care banner messaging, social network banner messaging, institutional account-based banner messaging, financial messaging, patient engagement and therapy initiation workflow. Its evidence-based physician engagement solution uses predictive analytics via machine learning methods applied to real-world data (RWD) to assist healthcare providers (HCPs). Its point of care banner messaging solution utilizes to deliver a variety of awareness and messaging within the clinical workflow, which can be tailored to meet the needs of each brand. Its Institutional Account-based Banner Messaging solution provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
10.32 USD
Average target price
16.17 USD
Spread / Average Target
+56.65%
Consensus
  1. Stock Market
  2. Equities
  3. OPRX Stock
  4. News OptimizeRx Corporation
  5. Earnings Flash (OPRX) OPTIMIZERX CORPORATION Reports Q1 Revenue $13.7M, vs. Street Est of $13.5M